stockrowChemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) Total debt
Chemed Corporation's total debt at the end of fiscal 2022 was $97.5M, down 58.5% from $235.0M in fiscal 2021. At the end of the quarter to 30 September 2026 it was $236.0M. Over the past ten years it has ranged from $91.3M (fiscal 2015) to $235.0M (fiscal 2021); the current reading is higher than 25% of that period. Chemed Corporation ranks 26th of 51 Medical Care Facilities companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $97.5M | (58.51%) |
| FY2021 | $235.0M | 74.07% |
| FY2020 | $135.0M | (2.88%) |
| FY2019 | $139.0M | 34.69% |
| FY2018 | $103.2M | 1.98% |
| FY2017 | $101.2M | (6.94%) |
| FY2016 | $108.8M | 19.18% |
| FY2015 | $91.3M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $236.0M | 68.57% |
| Jun 2026 | $140.0M | 53.51% |
| Mar 2026 | $91.2M | (7.88%) |
| Sep 2023 | $99.0M | (2.94%) |
| 34 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| DVA DaVita Inc. compare | $10.8B |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $8.7B |
| UHS Universal Health Services, Inc. compare | $5.7B |
| CON Concentra Group Holdings Parent, Inc. compare | $1.5B |
| OPCH Option Care Health, Inc. compare | $1.2B |
| PACS PACS Group, Inc. compare | $272.3M |
| LFST LifeStance Health Group, Inc. compare | $255.5M |
| CHE Chemed Corporation | $236.0M |
| ENSG The Ensign Group, Inc. compare | $198.7M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement